The demonstration that the administration of antisense oligonucleotides targeting NNMT to animals led to reduced weight gain and enhanced insulin sensitivity has prompted the development of NNMT inhibitors (NNMTis) for the treatment of obesity and type 2 diabetes. The gene discussed is NNMT; the disease is obesity due to melanocortin 4 receptor deficiency.